Aster Dm Healthcare Ltd. · NSE:ASTERDM
Aster Dm Healthcare — Q4 FY2020 Earnings Presentation
42 slides from Aster Dm Healthcare's earnings presentation, Jun 23, 2020
Slide 1: Cover letter to stock exchanges
June 23, 2020 The Secretary The Manager, Listing Department, Listing Department, BSE Limited, The National Stock Exchange of India Ltd 1st Floor, Phiroze Jeejeebhoy Towers Exchange Plaza, C-1, Block G Dalal Street, Mumbai 400001 Bandra Kurla Complex Scrip Code: 540975 Bandra (East), Mumbai 400051 Sc
Slide 2: Investor Presentation – For the quarter ended 31st March 2020
Investor Presentation – For the quarter ended 31st March 2020 1
Slide 3: Disclaimer
I I Disclaimer ❑ This presentation has been prepared by Aster DM Healthcare Limited (the "Company"), content of which was compiled from sources believed to be reliable for informational purposes only and are based on information regarding the Company and the economic, regulatory, market and other co
Slide 4: Aster – An Integrated Healthcare Provider
I I ~ , Aster – Overview ) j ,Aster – An Integrated Healthcare Provider Operational and Financial Overview Strategy and Leadership 3
Slide 5: Aster DM Healthcare – Business Overview
I I Aster DM Healthcare – Business Overview HOSPITALS One of Largest Private CAPACITY BEDS healthcare service providers GCC: 1,111 GCC: 12 4,804 25 India: 3,693 India: 13 operating in Asia (GCC & India) PATIENT VISITS – FY20 Present in 7 Countries CLINICS (UAE, Saudi Arabia, Qatar, Oman, ~19.4 mn GC
Slide 6: Aster DM Healthcare – Financial Overview
I I Aster DM Healthcare – Financial Overview Revenue - FV20 Revenue - FY20 <...------------ INR ~8,739 Cr ,_____; 26% EBITDA - FV20 EBITDA - FV20 Pharmacie 22% <...------------ INR ~968 Cr ,_____; Note: 1. Revenue and EBITDA shown above excludes other income; ; FY20 Revenue and EBITDA shown above is
Slide 7: Geographical Footprint
I Geographical Footprint I Hospitals – 12 GCC Clinics – 108 Pharmacies – 238 Hospitals – 13 Clinics – 9 INDIA United Arab Emirates Kerala • Medcare Hospital, Dubai Medcare Orthopaedics and Spine Hospital • Aster Medcity, Kochi • Aster Hospital Mankhool • Aster MIMS, Calicut • Medcare Women & Child H
Slide 8: Hospitals List
I I Hospitals List Hos pitals - GC C Medcare Hospital Al Raffa Hospital Al Raffa Hospital L oc ation Dubai, UAE Muscat, Oman Sohar, Oman C ommenc ement/ Ac quis ition Year 2007 2009 2010 - B ed C apac ity 64 86 78 Operational B eds 55 72 67 Owned /L eas ed Leased Leased Leased Geography GCC Capacity
Slide 9: Pipeline Projects
I I Pipeline Projects Owned / Hospitals - GCC Location Type Planned Beds Expected Completion Year Present Status Leased/O&M Aster Hospital Sharjah, UAE Greenfield 80 Q4 FY 2021 Construction Leased Aster Hospital Muscat, Oman Greenfield (Relocation) 145 Temporary Hold Leased Aster Hospital Internatio
Slide 10: The Aster DM Healthcare Edge
I I The Aster DM Healthcare Edge Aster DM – A Healthcare Ecosystem • Presence across hospitals, clinics & pharmacies and providing primary, secondary and tertiary/ quaternary care • Strategic and sizeable network of clinics enable patient feeder structure Differentiated Asset-light Business Model in
Slide 11: Aster DM Healthcare - Evolution
I I Aster DM Healthcare - Evolution Building the foundations New geographies, segments Brand “Aster” was formed, private equity Robust Growth across all segments and and service offerings investment, further expansion geographies; Rapid Expansion in India 2015: First clinic in Bahrain and in the Phi
Slide 12: Robust Growth Over Last 5 Years
I I ROBUST GROWTH OVER LAST 5 YEARS Outpatient Count {in mn) Inpatient Count {in '000) Aster DM - Revenue from Operations (INR Cr} 9.4 254 8,739 S '(f c,~G~ -? '2.0% 158 4.2 3,876 FYlS FY16 FY17 FY18 FY19 FY20 FYlS FY16 FY17 FY18 FY19 FY20 FYlS FY16 FY17 FY18 FY19 FY20 ..Coupled with capacity creati
Slide 13: Aster – An Integrated Healthcare Provider
I I Aster – Overview ) Aster – An Integrated Healthcare Provider Operational and Financial Overview Strategy and Leadership 12
Slide 14: Aster - An Integrated Healthcare Provider: FY20 Operational Information
I I Aster - An Integrated Healthcare Provider FY20 Operational Information 950+ 1,95,000+ Cardiovascular IP Discharges Surgeries ~5.8 mn Clinic OPD Visits 14,900+ General - ~ ~ 900+ Bariatric Clinics $ 1 Surgeries ' j/ \ Surgeries ■ ₹6 0% 2,300+ / \ I ----- Joint 1,400+ ~ 9.8 mn Replacements • o A S
Slide 15: Aster – A Healthcare Ecosystem
I I Aster – A Healthcare Ecosystem PATIENT LIFE CYCLE MANAGEMANT ▪ Aster, over 30 years, has created a healthcare eco-system across two geographical regions ▪ In GCC region, Aster’s primary care clinics i. act as the initial touch-points in the patient / ~ journey, while pharmacies and hospitals ,,•
Slide 16: GCC Healthcare – Unique Traits
I I GCC Healthcare – Unique Traits Healthcare market in GCC states have developed certain unique traits due to the higher expat Population {mn) and working age population I Expat%-> I~ Prevalence of Primary and Secondary Healthcare Facilities (Private Sector) ➢ Due to lower % of older population req
Slide 17: Aster - Awards & Service Excellence
I I Aster - Awards & Service Excellence JCI Accreditation Padma Shri Award AHPI Awards Medcare Hospital Dubai, Medcare Dr. Azad Moopen, Chairman & Managing Medcity, CMI, MIMS Calicut, WIMS, Orthopedics and Spine Hospitals, Medcare Director – Aster DM Healthcare received Aadhar, Medcare , Medcare Ort
Slide 18: Key Highlights – FY20 Q4
I I Key Highlights – FY20 Q4 Awards & Accreditations - India & GCC ➢ Ranked #187 on Fortune India’s – 500 Largest Corporations of India list in 2019 ➢ Aster MIMS Kottakkal wins India Brand Icon Award for Health Care Brand for Innovation (Hospital) for the Year 2019-20 ➢ Aster Hospital, Qatar assigne
Slide 19: Key Highlights – FY20 Q4
I I Key Highlights – FY20 Q4 Clinical Highlights - GCC ➢ Giant Antrochoanal Polyp operated on at Aster Sanad Hospital, Riyadh ➢ Cysts removed from around the brain of a 2-year-old toddler at Aster Sanad Hospital ➢ Aster Sanad Hospital helps patient suffering from Antiphospholipid Syndrome, to give b
Slide 20: Operational and Financial Overview
I I Aster – Overview ) ~ Aster – An Integrated Healthcare Provider Operational and Financial Overview Strategy and Leadership 19
Slide 21: Revenue and Profitability Snapshot – FY20 Q4
I I Revenue and Profitability Snapshot – FY20 Q4 Revenue from Operations EBITDA (excl. Other Income) PAT (Post-NCI) ~ 2201 ~ 2301 ~ 350 ~ 316 ~ 142 5% ..1.oo ~ 15.9% 9.5% ~ FY19 Q4 FY20 Q4 FY19 Q4 FY20 Q4 FY19 Q4 FY20Q4 ▪ Constant currency growth of Revenue, EBITDA and Adjusted PAT is ~2%, ~-12% and
Slide 22: Revenue and Profitability Snapshot – FY20
I I Revenue and Profitability Snapshot – FY20 Revenue from Operations EBITDA (excl. Other Income) PAT (Post-NCI) ~ ~ ~ 4.2% 10.8% FY19 FY20 FY19 FY20 FY19 FY20 ▪ Constant currency growth of Revenue, EBITDA and Adjusted PAT is ~8%, ~11% and ~1% respectively ▪ EBITDA growth had not translated into PAT
Slide 23: Geography-wise Financial – Snapshot (1/2)
I I Geography-wise Financial – Snapshot (1/2) GCC INDIA CONSOLIDATED FY19 Q4 FY20 Q4 FY19 Q4 FY20 Q4 FY19 Q4 FY20 Q4 Revenue (₹) 1,847 Cr 1,899 Cr 354 Cr 402 Cr 2,201 Cr 2,301 Cr G EBITDA (₹) 313 Cr 288 Cr 38 Cr 29 Cr 350 Cr 316 Cr G PAT (₹) 203 Cr 140 Cr 6 Cr 2 Cr 209 Cr 142 Cr G ▪ Growth in GCC re
Slide 24: Geography-wise Financial – Snapshot (2/2)
I I Geography-wise Financial – Snapshot (2/2) GCC INDIA CONSOLIDATED FY19 FY20 FY19 FY20 FY19 FY20 Revenue (₹) 6,649 Cr 7,108 Cr 1,314 Cr 1,631 Cr 7,963 Cr 8,739 Cr G EBITDA (₹) 742 Cr 808 Cr 121 Cr 160 Cr 863 Cr 968 Cr G PAT (₹) 341 Cr 337 Cr (8) Cr 5 Cr 333 Cr 342 Cr G Notes: 1. Revenue and EBITDA
Slide 25: Geography-wise Business – Snapshot (1/2)
I I Geography-wise Business – Snapshot (1/2) GCC INDIA CONSOLIDATED FY19 Q4 FY20 Q4 FY19 Q4 FY20 Q4 FY19 Q4 FY20 Q4 Total Capacity Beds 1,101 1,111 4,340* 3,693 5,441 4,804 Operational Beds 913 908 2,977* 2,530 3,890 3,438 ALOS (Days) 1.9 2.0 3.7 3.5 3.0 2.9 Occupancy3 54% 58% 65% 56% 62% 57% Outpat
Slide 26: Geography-wise Business – Snapshot (2/2)
I I Geography-wise Business – Snapshot (2/2) GCC INDIA CONSOLIDATED FY19 FY20 FY19 FY20 FY19 FY20 Total Capacity Beds 1,101 1,111 4,340* 3,693 5,441 4,804 Operational Beds 913 908 2,977* 2,530 3,890 3,438 ALOS (Days) 2.0 1.9 3.6 3.5 3.0 2.9 Occupancy3 56% 56% 63% 61% 61% 60% Outpatient Visits ~1.42
Slide 27: Segmental Performance FY20-Q4
I I Segmental Performance FY20-Q4 Growth % Unallocate Unallocate India - India - GCC GCC d& GCC GCC d& FY20 Q4 GCC Clinics Hospitals & Total GCC Clinics Hospitals & Total Hospitals Pharmacies Elimination Hospitals Pharmacies Elimination Clinics Clinics s s No. of Business Units (#) 12 108 238 H-13,
Slide 28: Segmental Performance FY20
I I Segmental Performance FY20 India - Unallocated India - Unallocated GCC GCC GCC GCC FY20 FY GCC Clinics Hospitals & & Total GCC Clinics Hospitals & & Total Hospitals Pharmacies Hospitals Pharmacies Clinics Eliminations Clinics Eliminations No. of Business Units (#) 12 108 238 H-13, C-9 NA 380 Ope
Slide 29: Maturity Wise Hospital Performance – GCC FY20
I I Maturity Wise Hospital Performance – GCC FY20 Key Performance indicators Revenue Maturity Hospitals Operational Beds (INR in Crs.) EBITDA ARPOBD Occupancy EBITDA % (INR in Cr.) 18% 27% ₹28 4 38% 5.3% 0-3 Years ₹ 532 242 ₹ ~165,300 Over 3 Years 82% 73% ₹ ~165,300 62% ₹401 8 ₹2,445 666 16.4% 12 ₹
Slide 30: Maturity Wise Hospital Performance – India FY20
I I Maturity Wise Hospital Performance – India FY20 Key Performance indicators Revenue Maturity Hospitals Operational Beds (INR in Crs.) EBITDA ARPOBD Occupancy EBITDA % (INR in Cr.) ₹ 21 31% 13% 67% 4.2% 0-3 Years 2 ₹ 500 330 ₹ ~24,500 Over 3 Years 69% 87% ₹ ~28,200 60% ₹162 10 ₹1,131 2,200 14.3% 1
Slide 31: Financial Summary – Profitability Statement (1/2)
I I Financial Summary – Profitability Statement (1/2) Particulars (INR Cr) FY20 Q3 FY19 Q4 FY20 Q4 Gw% Revenue from operations 2,322 2,201 2,301 5% Material consumption 695 663 697 Doctors cost 501 450 487 Employee cost (excl. doctors) 410 396 423 Other expenses 298 246 273 EBITDAR 418 446 422 -5% E
Slide 32: Financial Summary – Profitability Statement (2/2)
I I Financial Summary – Profitability Statement (2/2) Particulars (INR Cr) FY19 FY20 Grt% Revenue from operations 7,963 8,738.50 10% Material consumption 2,420 2,635 Doctors cost 1,720 1,926 Employee cost (excl. doctors) 1,568 1,666 Other expenses 1,033 1,131 EBITDAR 1,221 1,379 13% EBITDAR % 15.3%
Slide 33: Financial Summary – Balance Sheet & Ratios
I I Financial Summary – Balance Sheet & Ratios As at Mar 31, As at Mar 31, Particulars (INR Cr) 2019 2020 LIABILITIES Shareholders Equity 3,214 3,272 Minority Interest 466 446 Gross Debt 2,672 2,972 Lease Liabilities - INDAS116 - 2,632 Other current and non-current liabilities 2,584 3,115 Total Liab
Slide 34: Financial Summary – INDAS116 Impact FY20Q4
I I Financial Summary – INDAS116 Impact FY20Q4 GCC India Consolidated FY20 Q4 - FY20 Q4 - FY20 Q4 - before before before Particulars (INR Cr) FY19 Q4 INDAS116 INDAS 116 FY20 Q4 FY19 Q4 INDAS116 INDAS 116 FY20 Q4 FY19 Q4 INDAS116 INDAS 116 FY20 Q4 Revenue 1,847.0 1,899.4 - 1,899.4 354.0 402.0 - 402.0
Slide 35: Financial Summary – INDAS116 Impact FY20
I I Financial Summary – INDAS116 Impact FY20 GCC India Consolidated FY20 - FY20 - FY20 - before before before Particulars (INR Cr) FY19 INDAS116 INDAS 116 FY20 FY19 INDAS116 INDAS 116 FY20 FY19 INDAS116 INDAS 116 FY20 Revenue 6,648.7 7,107.9 7,107.9 1,314.0 1,630.6 1,630.6 7,962.7 8,738.5 8,738.5 Co
Slide 36: Strategy and Leadership
I I Aster – Overview ) Aster – An Integrated Healthcare Provider Operational and Financial Overview Strategy and Leadership 35
Slide 37: ADMHL – Strategy & Outlook (1/2)
I I ADMHL – Strategy & Outlook (1/2) Strengthening of hub and A comprehensive human Scalable systems Strengthening of our medical spoke model in GCC resource strategy utilizing our implementation, tightly tourism network geographical diversity and integrated with catering to future growth operations
Slide 38: ADMHL – Strategy & Outlook (2/2)
I I ADMHL – Strategy & Outlook (2/2) Profitability growth & brand Building of brand, talent Specialized, asset-light Cost Optimization positioning using product- and capability in KSA – a growth in India mix and technology key market in GCC • Focus on margin expansion through • There is significant
Slide 39: India Strategy
I I India Strategy India is geographically well positioned for Focus on In line with medical tourism focus on large format from the GCC hospitals in Tier 1 derisking states, MENA business – cities – Hospitals region and South- in Tier 1 cities The new National Health Protection Scheme target of 25%
Slide 40: Aster Leadership Team
I I Aster Leadership Team Dr. Azad Moopen Dr. Harish Pillai Veneeth Purushotaman Chairman and Managing Director Chief Executive Officer – India Chief Information Officer Alisha Moopen Jobilal M. Vavachan Chief Executive Officer, Aster Fara Siddiqi Deputy Managing Director Pharmacies, Aster Clinics –
Slide 41: Aster Board of Directors
I I Aster Board of Directors strategy andleadership Dr. Azad Moopen C. John George Suresh M. Kumar Chairman and Managing Director Independent Director Independent Director Dr Layla Mohamed Biju Varkkey t Alisha Moopen Deputy Managing Director Al-Marzooqi Independent Director Independent Director Dan
Slide 42: Thank You
JHANK YOU 41 www.asterdmhealthcare.com
Aster DM Healthcare — Q4 FY2020 Earnings Presentation on 6ix